Walleye Trading’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,358
Closed -$203K 4723
2025
Q4
$206K Buy
9,358
+2,240
+31% +$40.4K ﹤0.01% 3375
2025
Q3
$86.4K Buy
7,118
+975
+16% +$13.2K ﹤0.01% 3776
2025
Q2
$115K Buy
+6,143
New +$122K ﹤0.01% 3525
2024
Q1
Sell
-67
Closed -$1.79K 5356
2023
Q4
$1.98K Buy
+67
New +$1.39K ﹤0.01% 4824
2022
Q2
Sell
-3,409
Closed -$280K 5668
2022
Q1
$396K Buy
+3,409
New +$398K ﹤0.01% 3140
2021
Q4
Sell
-1,709
Closed -$231K 5874
2021
Q3
$204K Sell
1,709
-2,815
-62% -$310K ﹤0.01% 3826
2021
Q2
$441K Buy
+4,524
New +$403K ﹤0.01% 3057
2021
Q1
Sell
-6,480
Closed -$620K 5301
2020
Q4
$620K Buy
6,480
+2,400
+59% +$247K ﹤0.01% 2466
2020
Q3
$463K Sell
4,080
-502
-11% -$52.7K ﹤0.01% 2307
2020
Q2
$453K Buy
4,582
+1,589
+53% +$127K ﹤0.01% 2350
2020
Q1
$193K Buy
+2,993
New +$210K ﹤0.01% 2627
2019
Q2
Sell
-3,347
Closed -$216K 4483
2019
Q1
$213K Buy
+3,347
New +$176K ﹤0.01% 2977

Other funds holding TNDM

Walleye Trading's TNDM Position: Q1 2026 in Review

Walleye Trading sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 9,358 shares — an estimated $203K sold.

Walleye Trading first reported a position in TNDM in Q1 2019 and held it in 12 quarters. The position peaked at $620K in Q4 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Walleye Trading reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 9,358 Tandem Diabetes Care shares in Q1 2026, an estimated $203K.
  • Walleye Trading first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 12 quarters.
  • Walleye Trading's Tandem Diabetes Care position peaked at $620K in Q4 2020.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.